Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672700 | SCV000797834 | likely pathogenic | Bardet-Biedl syndrome 13; Meckel syndrome, type 1; Joubert syndrome 28 | 2018-02-13 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002513702 | SCV003442503 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome | 2022-05-16 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 56625). This variant is also known as 50insCCGGG, P17fsX163. This premature translational stop signal has been observed in individual(s) with Meckel syndrome (PMID: 16415886). This variant is present in population databases (rs386834051, gnomAD 0.002%). This sequence change creates a premature translational stop signal (p.Asp19Alafs*36) in the MKS1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MKS1 are known to be pathogenic (PMID: 19466712, 24886560, 26490104). |
Baylor Genetics | RCV003474637 | SCV004194927 | pathogenic | Bardet-Biedl syndrome 13 | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050038 | SCV000082447 | probable-pathogenic | Meckel syndrome, type 1 | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |